wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36319038-83D403CB-3F6A-4BAC-A9C0-3D50A5E93915
Q36319038-83D403CB-3F6A-4BAC-A9C0-3D50A5E93915
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36319038-83D403CB-3F6A-4BAC-A9C0-3D50A5E93915
Managing patients treated with bevacizumab combination therapy.
P2860
Q36319038-83D403CB-3F6A-4BAC-A9C0-3D50A5E93915
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36319038-83D403CB-3F6A-4BAC-A9C0-3D50A5E93915
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7bb4355b743d216a69c3f642cf041b5522fcd958
P2860
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.